title: Non-Hodgkin's lymphoma related eosinophilic endomyocardial disease.
abstract: Two patients with eosinophilic endomyocardial disease related to peripheral T-cell lymphomas are reported. Both patients were free of cardiac symptoms at presentation and during follow-up. Routine two dimensional echocardiography revealed bi-apical ventricular obliteration, which was also seen on MR imaging. On the T1-weighted sequence, the thickened endocardium appeared with an isointense signal. Gadolinium DOTA provided an enhanced contrast of the internal part of the left ventricular wall. On T2-weighted sequence, a thin hypointense curvilinear structure drew a dividing line between the internal, endocardial, and the external, myocardial area. Left-ventricular systolic and diastolic functions remained unaltered during subsequent follow-up.
authors: Department of Haematology, Hôpital Saint Louis, Paris, France.
authors: J J
authors: JJ
authors: Monsuez
authors: E
authors: E
authors: de Kerviler
authors: M
authors: M
authors: Barboteu
authors: P
authors: P
authors: Pautier
authors: D
authors: D
authors: Simon
authors: J
authors: J
authors: Frija
authors: J R
authors: JR
authors: Le Gall
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000175:diagnosis / Q000209:etiology*; D003287:Contrast Media; D004317:Doxorubicin / Q000008:administration & dosage; D004452:Echocardiography; D018619:Echocardiography, Doppler, Pulsed; D004699:Endocardium / Q000473:pathology; D015251:Epirubicin / Q000008:administration & dosage; D006571:Heterocyclic Compounds; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000175:diagnosis / Q000209:etiology*; D016411:Lymphoma, T-Cell, Peripheral / Q000150:complications* / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D008297:Male; D009206:Myocardium / Q000473:pathology; D009942:Organometallic Compounds
chemical_list: D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; D015251:Epirubicin; D004317:Doxorubicin; C050823:gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate